Media Room
-1920x1080.webp&w=3840&q=90 "How we are Making Pharmaceutical Quality Scalable, and Accessible, with AI")
How we are Making Pharmaceutical Quality Scalable, and Accessible, with AI
At Axmed, we're using AI-powered tools to transform prequalification or GMP/GDP audit, from day-long manual processes into real-time quality intelligence.
The Certificate Was Valid. The Medicine Was Not. Rethinking medicine quality in East Africa's supply chain
The medicine reached the patient. The label was correct. But it did not work.
Axmed Named #2 Most Innovative Company in Healthcare by Fast Company
Weโre honoured to have been named in Fast Company's Most Innovative Companies of 2026, ๐ฟ๐ฎ๐ป๐ธ๐ฒ๐ฑ #๐ฎ ๐ถ๐ป ๐๐ฒ๐ฎ๐น๐๐ต๐ฐ๐ฎ๐ฟ๐ฒ ๐ด๐น๐ผ๐ฏ๐ฎ๐น๐น๐!
Axmed Secures $6M Grant Funding to Scale the Global Infrastructure for Access to Healthcare Products
Axmed, a health technology company headquartered in Switzerland with regional headquarters in Nairobi, Kenya, today announced it has been awarded $6 million in non-dilutive grant funding from the Gates Foundation to expand
Axmed Stakeholder Letter 2025
This report reflects our progress, but it also details the trade-offs and challenges that come with doing hard things at scale.
Axmed and LifeNet International Announce Transformative Partnership to Expand Access to Essential Maternal and Newborn Health Products
Postpartum haemorrhage (PPH), is the leading cause of maternal death in Sub-Saharan Africa. Standard care in these settings often relies on visual estimates of blood loss, which frequently underestimates severity and delays critical interventions.
Future-Proofing Health Procurement in a Post - US Aid World
The dust has begun to settle after a turbulent year in development financing, providing space to ask: what comes next?
-1920x1080.webp&w=3840&q=90 "Procurement as the Invisible Bottleneck in Global Health")
Procurement as the Invisible Bottleneck in Global Health
Thousands of procurement units, hospitals, and pharmacies continue to operate in isolation, each navigating suppliers, logistics providers, and funders through bespoke and largely manual processes.
Access to Medicines Will Be Won or Lost on How Markets Are Built
There is a persistent misconception in global health: that expanding access to medicines requires sacrificing commercial viability.